Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

Breakthrough Discovery: Scientists Unlock a New Way to Keep Your Bones Strong for Life

Strong bones are essential for a healthy and active life. As we age, however, our bones naturally lose strength, making them more fragile and prone to fractures. This condition, known as Osteoporosis, affects millions of people worldwide—especially older adults and women after menopause.

Now, in an exciting scientific breakthrough, researchers have discovered a new way to strengthen bones from within. By targeting a little-known receptor called GPR133 receptor and activating it with a newly identified compound known as AP503 compound, scientists may have found a powerful method to not only prevent bone loss but also rebuild weakened bones.


Understanding the Challenge of Weak Bones

Bones are not lifeless structures—they are constantly renewing themselves. This process involves two types of cells:

  • Osteoblasts: Cells that build new bone

  • Osteoclasts: Cells that break down old bone

For healthy bones, these two processes must remain in balance. But in conditions like osteoporosis, this balance is disturbed. Bone breakdown happens faster than bone formation, leading to reduced density and increased risk of fractures.

Today’s treatments mainly aim to slow down bone loss. However, they often come with limitations, such as side effects or limited ability to rebuild already damaged bone. This has pushed scientists to search for better, safer, and more effective solutions.


The Role of GPR133: A Hidden Key to Bone Strength

Recent research has highlighted the importance of the GPR133 receptor, a member of the larger family of proteins known as G protein-coupled receptors (GPCRs). These receptors sit on the surface of cells and act like communication hubs, sending signals that control various functions in the body.

Although GPCRs are widely used as drug targets, this specific subgroup—called adhesion GPCRs—has not been studied extensively until now.

Scientists found that GPR133 plays a crucial role in maintaining bone health. When this receptor does not function properly, bone density drops significantly. In fact, animal studies showed that mice with defective GPR133 developed symptoms similar to osteoporosis at an early age.

This discovery clearly shows that GPR133 is not just important—it is essential for strong and healthy bones.


A New Compound with Powerful Effects

To activate this receptor, researchers turned to advanced computer-based methods to identify potential molecules. This led to the discovery of the AP503 compound.

AP503 works by stimulating the GPR133 receptor, effectively “switching on” its bone-strengthening signals. When tested in mice, the results were remarkable:

  • Increased bone density

  • Improved bone strength

  • Reversal of osteoporosis-like damage

What makes this especially promising is that the compound worked not only in healthy mice but also in those already suffering from bone weakness.


How This Discovery Works Inside the Body

The GPR133 receptor is activated naturally through interactions between bone cells and physical forces like movement and pressure. Once activated, it sends signals that:

  • Boost the activity of osteoblasts (bone-building cells)

  • Reduce the activity of osteoclasts (bone-breaking cells)

This dual action is critical. Instead of simply slowing bone loss, it actively promotes new bone formation while limiting breakdown.

The AP503 compound mimics this natural activation process. By doing so, it restores balance in bone remodeling and leads to stronger, denser bones.


Benefits Beyond Bone Health

Interestingly, the benefits of activating GPR133 may extend beyond bones. Earlier studies have shown that the same pathway also improves muscle strength.

This is especially important for older adults. Weak muscles and fragile bones together increase the risk of falls, fractures, and loss of independence. A treatment that strengthens both systems could dramatically improve quality of life.

By targeting both bone and muscle health, therapies based on GPR133 could offer a more complete solution for aging populations.


Why This Matters for the Future

Osteoporosis is often called a “silent disease” because it develops without obvious symptoms. Many people only realize they have it after experiencing a fracture. By that time, significant damage has already occurred.

This new discovery changes the direction of treatment. Instead of only managing the condition, future therapies could:

  • Prevent bone loss before it begins

  • Rebuild damaged bone

  • Maintain lifelong bone strength

The identification of the GPR133 receptor as a key regulator opens up a completely new path for medical research and drug development.


A Decade of Research Behind the Breakthrough

This achievement did not happen overnight. It is the result of more than ten years of dedicated research into adhesion GPCRs. Scientists have worked to understand how these receptors function and how they can be targeted for medical use.

The discovery of AP503 and its effects on GPR133 is a major milestone in this journey. It highlights how modern technologies, such as computer-based screening, can accelerate the search for new treatments.


What Comes Next?

While the results are highly promising, more research is still needed before this treatment can be used in humans. Scientists are now:

  • Studying the long-term safety of AP503

  • Exploring how GPR133 functions in different parts of the body

  • Investigating potential applications for other diseases

Clinical trials will be a crucial next step. If successful, this could lead to a new class of medications designed to keep bones strong throughout life.


Final Thoughts

The discovery of the GPR133 receptor and the AP503 compound marks a turning point in bone health research. For the first time, scientists may have found a way to not just slow bone loss but actually rebuild and strengthen bones from within.

For millions of people affected by Osteoporosis, this offers new hope. And for future generations, it brings us closer to a world where strong, healthy bones can be maintained for life.

If further research confirms these findings, this breakthrough could transform how we treat bone diseases—and help people stay active, independent, and healthy well into old age.

Journal Reference:

  1. Juliane Lehmann, Hui Lin, Zihao Zhang, Maren Wiermann, Albert M. Ricken, Franziska Brinkmann, Jana Brendler, Christian Ullmann, Luisa Bayer, Sandra Berndt, Anja Penk, Nadine Winkler, Franz Wolfgang Hirsch, Thomas Fuhs, Josef Käs, Peng Xiao, Torsten Schöneberg, Martina Rauner, Jin-Peng Sun, Ines Liebscher. The mechanosensitive adhesion G protein-coupled receptor 133 (GPR133/ADGRD1) enhances bone formationSignal Transduction and Targeted Therapy, 2025; 10 (1) DOI: 10.1038/s41392-025-02291-y

Comments

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...